You are currently viewing Dafni Bika, Dr.

Dafni Bika, Dr.

Senior Vice President and Head of Pharmaceutical Technology & Development at AstraZeneca

Dafni Bika, Ph.D. is Senior Vice President and Head of Pharmaceutical Technology & Development at AstraZeneca, where she leads a global organization of 1800 scientists and engineers responsible for transforming innovative molecules into approved medicines. With over 30 years of experience spanning CMC pharmaceutical development, manufacturing science and technology, and commercialization, she has held leadership roles at AstraZeneca, Bristol Myers Squibb, Merck, and Procter & Gamble.  She has enabled the commercialization of more than 30 new molecular entities including blockbuster medicines such as Farxiga, Tagrisso, Eliquis, Orencia and Janumet.

Dafni is widely recognized as a CMC leader advancing innovative technologies at scale and she has pioneered an AI-Development multi-Agent (AIDA)  to accelerate formulation and process development. Dafni holds a Ph.D. in Materials Science and Engineering from the University of Pennsylvania, an M.Sc. in Materials Science and Engineering from the University of Rochester, and a Diploma in Chemical Engineering from the National Technical University of Athens, Greece.